PGE1 vs inositol niacinate
Cardiovascular mortality · people with critical limb ischaemia
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
PGE1 showed no clear difference in adverse events (participants) compared with inositol niacinate (low certainty).
PGE1 showed no clear difference in rest‐pain relief compared with inositol niacinate (low certainty).
PGE1 showed no clear difference in ulcer healing compared with inositol niacinate (low certainty).